Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

VML-670 enters phase II program for antidepressant-related sexual dysfunction

May 24, 2002

Novel treatments for male erectile dysfunction

May 17, 2002

Rho kinase as a potential target for erectile dysfunction Rx

May 17, 2002

CYC-202 to be evaluated in glomerulonephritis

May 16, 2002

Data support inhibition of hypocretin system in the treatment of urinary incontinence

May 16, 2002

Phase II trials begin in Europe and U.S. for KW-7158

May 16, 2002

Tadalafil: a new treatment option for men with erectile dysfunction

May 14, 2002

Tadalafil, an important new treatment option for most men with ED

May 13, 2002

Alpha1-adrenoceptor antagonists useful for urological disorders

May 10, 2002

YC-1 may be useful for treating erectile dysfunction

May 10, 2002

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...